Product Information
DIVALPROEX DR 125 MG CAP SPRNK is a generic product labeled by Major Pharmaceuticals, priced at $0.2008 per EA under NDC 00904661561. Its NADAC has been published 389 times since Apr 24, 2019.
FDA first approved this application on Jan 23, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904661561
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078979FDA Approved
1/23/2009
TE Code
AB
On Market Since
1/23/2009
Pharmacological Classes
Price Statistics
The NADAC for DIVALPROEX DR 125 MG CAP SPRNK has been published 389 times since Apr 24, 2019, and over the history we have for it it has declined 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2008 per EA |
|---|---|
| All-time high | $0.4067 (Aug 14, 2019) |
| All-time low | $0.1772 (Nov 20, 2024) |
| 52-week high | $0.2196 |
| 52-week low | $0.1959 |
| Median price | $0.2774 |
| Average price | $0.2848 |
| Largest weekly change | +33.9% (Jun 19, 2024) |
| Weeks tracked | 389 |
| Tracking since | Apr 24, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Divalproex sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIVALPROEX DR 125 MG CAP SPRNK?
The current National Average Drug Acquisition Cost (NADAC) for DIVALPROEX DR 125 MG CAP SPRNK, manufactured by Major Pharmaceuticals, is $0.2008 per EA (NDC 00904661561), effective Sep 30, 2026.
How has the price of DIVALPROEX DR 125 MG CAP SPRNK changed over time?
Over the history we have for it, the NADAC for DIVALPROEX DR 125 MG CAP SPRNK has declined 46.3%. It has been tracked across 389 weekly CMS publications since Apr 24, 2019.
What are the highest and lowest recorded NADAC prices for DIVALPROEX DR 125 MG CAP SPRNK?
Since Apr 24, 2019, the NADAC for DIVALPROEX DR 125 MG CAP SPRNK has ranged from a low of $0.1772 (Nov 20, 2024) to a high of $0.4067 (Aug 14, 2019), with a median of $0.2774 per EA.
Are there cheaper alternatives to DIVALPROEX DR 125 MG CAP SPRNK?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIVALPROEX DR 125 MG CAP SPRNK in a comparable dosage form, but none are currently priced below it.
Who manufactures DIVALPROEX DR 125 MG CAP SPRNK?
DIVALPROEX DR 125 MG CAP SPRNK (NDC 00904661561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.